Company news
Infant Bacterial Therapeutics AB news in 2026
Infant Bacterial Therapeutics AB's news releases, calls and decks from 2026, newest first.
Annual General Meeting of Infant Bacterial Therapeutics
May 7, 2026
IBT_B: Operating loss widened in Q1 2026 as IBP-9414 nears FDA submission and commercialization
May 6, 2026
Correction: Notice of Annual General Meeting of Infant Bacterial Therapeutics
April 2, 2026
Notice of Annual General Meeting of Infant Bacterial Therapeutics
March 30, 2026
Infant Bacterial Therapeutics AB publishes the Annual Report for 2025
March 27, 2026
Infant Bacterial Announces Phase III IBP-9414 Study Results
March 3, 2026
Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln
February 6, 2026